Biomarkers and surrogates in clinical studies

Methods in Molecular Biology

Volumn 473, Issue , 2009, Pages 137-154

  Rigatto, Claudio ^a   Barrett, Brendan J ^a  

^a St Boniface General Hosptial   (Canada)

Author keywords

Biomarkers; diagnosis; intervention studies; prognosis; risk factors; surrogate outcomes; validation studies

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL TRIAL; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; PREDICTION AND FORECASTING; REVIEW; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 59649087876     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-385-1_8     Document Type: Article

References (15)

1. Wagener, G., Jan, M., Kim, M., Mori, K., Barasch, J. M., Sladen, R. N., Lee, H. T. (2006). Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105, 485-491. (Pubitemid 44310430)
2. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Therap 69, 89-95.
3. Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., Benjamin, E. J., D'Agostino, R. B., Vasan, R. S. (2006). Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355, 2631-2639. (Pubitemid 44969122)
4. Sackett, D., Haynes, R., Guyatt, G., Tug-well, P. (1991). The interpretation of diagnostic data, in Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd ed. Little, Brown and Company, Toronto.
5. Kleinbaum, D. G. (1996). Survival Analysis: A Self-Learning Text. Springer-Verlag, New York.
6. Cox, D. R., Oakes, D. (1984). Analysis of Survival Data. Chapman and Hall/CRC, Boca Raton, FL.
7. Pencina, M. J., D'Agostino, R. B. (2004). Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23, 2109-2123. (Pubitemid 38968032)
8. Peduzzi, P., Concato, J., Kemper, E.,. Hol-ford, T. R., Feinstein, A. (1996). A simulation of the number of events per variable in logistic regression analysis. J Clin Epidemiol 99, 1373-1379. (Pubitemid 27028925)
9. Hanley, J., McNeil, B. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36. (Pubitemid 12142173)
10. Mulherin, S. A., Miller, W. C. (2002). Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 137, 598-602.
11. Nissen, S. E., Tardif, J. C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., Tuzcu, E. M., ILLUSTRATE Investigators. (2007) Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356, 1304-1316. (Pubitemid 46513296)
12. LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J. C., Gotto, A. M., Greten, H., Kastelein, J. J., Shepherd, J., Wenger, N. K. (2005) Treating to new targets (TNT) investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352, 1425-1435. (Pubitemid 40471450)
13. Baker A. G., Kramer B. S. (2003). A perfect correlate does not a surrogate make. BMC Med Res Methodol 3, 16-21.
14. Prentice R. L. (1989). Surrogate endpoints in clinical trials: Definitions and operational criteria. Stat Med 8, 431-430.
15. Gail, M. H., Pfeiffer, R., Houwelingen, H. C., Carroll, R. J. (2001). On meta-analytic assessment of surrogate outcomes. Biosta-tistics 3, 231-246. (Pubitemid 33213533)